| [1] | Howard, A., Hope, W., and Gerada, A. (2023). ChatGPT and antimicrobial advice: the end of the consulting infection doctor. Lancet. Infect. Dis. 23: 405−406. DOI: 10.1016/S1473-3099(23)00113-5. |
| [2] | Kung, T.H., Cheatham, M., Medenilla, A., et al. (2023). Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models. PLOS Digit. Health 2: e0000198. DOI: 10.1371/journal.pdig.0000198. |
| [3] | Lee, P., Bubeck, S., and Petro, J. (2023). Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. N. Engl. J. Med. 388: 1233−1239. DOI: 10.1056/NEJMsr2214184. |
| [4] | Li, H., Moon, J.T., Iyer, D., et al. (2023). Decoding radiology reports: Potential application of OpenAI ChatGPT to enhance patient understanding of diagnostic reports. Clin. Imaging. 101: 137−141. DOI: 10.1016/j.clinimag.2023.06.008. |
| [5] | Zhou, Z., Wang, X., Li, X., and Liao, L. (2023). Is ChatGPT an Evidence-based Doctor. Eur. Urol. 23: S0302−2838. DOI: 10.1016/j.eururo.2023.03.037. |
| Yin C., Zheng J., Liu J., et al., (2023). ChatGPT: The doctor's assistant? The Innovation Medicine 1(3), 100034. https://doi.org/10.59717/j.xinn-med.2023.100034 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
The limitations and benefits of ChatGPT.